Article
Agonist binding affinity determines palmitoylation of the glucagon-like peptide-1 receptor…
medRxiv · 2018 · Buenaventura, T.; Laughlin, W. E.; Bitsi, S.; Burgoyne, T.; Lyu, Z.; Oqua, A. I.; Norman, H.; McGlone, E. R.; Klymchenko, A. S.; Correa, I. R.; Walker, A.; Inoue, A.; Hanyaloglou, A.; Rutter, G. A.; Bloom, S. R.; Jones, B.; Tomas, A.
Key facts
| Title | Agonist binding affinity determines palmitoylation of the glucagon-like peptide-1 receptor and its functional interaction with plasma membrane nanodomains in pancreatic beta cells |
|---|---|
| First author | Buenaventura, T.; Laughlin, W. E.; Bitsi, S.; Burgoyne, T.; Lyu, Z.; Oqua, A. I.; Norman, H.; McGlone, E. R.; Klymchenko, A. S.; Correa, I. R.; Walker, A.; Inoue, A.; Hanyaloglou, A.; Rutter, G. A.; Bloom, S. R.; Jones, B.; Tomas, A. |
| Journal | medRxiv |
| Published | Dec 10, 2018 |
| DOI | 10.1101/492496 |
| Devices mentioned | K800781, K883302 |
| Product codes mentioned | KIP, KIT, NDS, NJT, KIS |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1